Date |
Time |
Source |
Heading |
23/5/2024 | 06:51 | ALNC | IN BRIEF: MaxCyte inks deal with Legend Biotech for tech.. |
22/5/2024 | 22:05 | GLOBE | MaxCyte Signs Strategic Platform License Agreement with.. |
22/5/2024 | 22:05 | UK RNS | MaxCyte, Inc. Signing of Strategic Platform License |
20/5/2024 | 16:00 | UK RNS | MaxCyte, Inc. Holding(s) in Company |
14/5/2024 | 23:55 | UK RNS | MaxCyte, Inc. Holding(s) in Company |
08/5/2024 | 18:46 | ALNC | MaxCyte shares rise amid double-digit revenue increase |
08/5/2024 | 16:05 | UK RNS | MaxCyte, Inc. Filing of Form 10-Q |
08/5/2024 | 16:00 | UK RNS | MaxCyte, Inc. First Quarter Results |
08/5/2024 | 06:05 | GLOBE | MaxCyte Reports First Quarter 2024 Financial Results and.. |
03/5/2024 | 16:00 | UK RNS | MaxCyte, Inc. Notice of AGM |
02/5/2024 | 02:04 | UK RNS | MaxCyte, Inc. Total Voting Rights |
10/4/2024 | 22:05 | GLOBE | MaxCyte to Report First Quarter 2024 Financial Results on.. |
10/4/2024 | 22:05 | UK RNS | MaxCyte, Inc. Notice of Results |
03/4/2024 | 17:00 | UK RNS | MaxCyte, Inc. Total Voting Rights and Block Listing Return |
03/4/2024 | 01:19 | ALNC | TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian.. |
02/4/2024 | 23:05 | UK RNS | MaxCyte, Inc. Signing of Strategic Platform License |
02/4/2024 | 23:05 | GLOBE | MaxCyte Signs Strategic Platform License with Be Biopharma.. |
02/4/2024 | 17:00 | UK RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
20/3/2024 | 21:16 | UK RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR.. |
20/3/2024 | 21:05 | UK RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR.. |
13/3/2024 | 22:54 | ALNC | IN BRIEF: MaxCyte loss widens in 2023 as core revenue.. |
13/3/2024 | 18:05 | UK RNS | MaxCyte, Inc. Filing of form 10-K for FY ended December 31,.. |
13/3/2024 | 18:00 | UK RNS | MaxCyte, Inc. Reports Q4 & FY 2023 Financial Results |
13/3/2024 | 07:05 | UKREG | MaxCyte Reports Fourth Quarter and Full Year 2023 Financial.. |
06/3/2024 | 19:58 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
06/3/2024 | 07:43 | ALNC | EARNINGS: dotdigital eyes rosy future; Beeks Financial turns.. |
05/3/2024 | 18:00 | UK RNS | MaxCyte, Inc. Preliminary FY Results & 2024 Guidance |
05/3/2024 | 08:05 | UKREG | MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023.. |
02/3/2024 | 04:57 | UK RNS | MaxCyte, Inc. Total Voting Rights |
29/2/2024 | 20:21 | UK RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
26/2/2024 | 18:00 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
10/2/2024 | 00:05 | UK RNS | MaxCyte, Inc. Notice of Results |
10/2/2024 | 00:05 | UKREG | MaxCyte to Report Fourth Quarter and Full Year 2023.. |
01/2/2024 | 20:24 | UK RNS | MaxCyte, Inc. Total Voting Rights |
31/1/2024 | 18:00 | UK RNS | MaxCyte, Inc. Director/PDMR Shareholding |
31/1/2024 | 01:29 | UK RNS | MaxCyte, Inc. Holding(s) in Company |
31/1/2024 | 00:58 | ALNC | IN BRIEF: MaxCyte signs licencing deal with cell therapy.. |
31/1/2024 | 00:05 | UKREG | MaxCyte and Wugen Sign Strategic Platform License to.. |
31/1/2024 | 00:05 | UK RNS | MaxCyte, Inc. Signing of Strategic Platform License |
30/1/2024 | 04:56 | ALNC | IN BRIEF: MaxCyte chief scientific officer leaves firm |
30/1/2024 | 03:52 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
29/1/2024 | 18:00 | UK RNS | MaxCyte, Inc. Filing of Form 8-K |
24/1/2024 | 05:39 | ALNC | TRADING UPDATES: Esken's Southend Airport faces further.. |
24/1/2024 | 00:05 | UKREG | MaxCyte, Inc. Signing of Strategic Platform License |
24/1/2024 | 00:05 | GLOBE | MaxCyte Signs Strategic Platform License with Imugene to.. |
09/1/2024 | 23:18 | ALNC | MaxCyte's strategic platform licences redeem otherwise.. |
09/1/2024 | 18:00 | UKREG | MaxCyte, Inc. Preliminary Unaudited Q4 and FY 2023 Results |
09/1/2024 | 08:05 | GLOBE | MaxCyte Announces Preliminary Unaudited Fourth Quarter and.. |
05/1/2024 | 18:00 | UKREG | MaxCyte, Inc. Grant of Options and PDMR Dealing |
04/1/2024 | 01:04 | ALNC | MaxCyte teams with Singapore-based Lion to support TCR-T.. |